Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;53(6):722-728.
doi: 10.1016/j.dld.2020.12.002. Epub 2021 Jan 11.

Cytomegalovirus gastritis: Clinicopathological profile

Pai-Jui Yeh  1 , Cheng-Tang Chiu  2 , Ming-Wei Lai  3 , Ren-Chin Wu  4 , Chia-Jung Kuo  2 , Jun-Te Hsu  5 , Ming-Yao Su  6 , Puo-Hsien Le  7
Affiliations

Cytomegalovirus gastritis: Clinicopathological profile

Pai-Jui Yeh et al. Dig Liver Dis. 2021 Jun.

Abstract

Background: Cytomegalovirus (CMV) gastritis is occasionally reported in case reports and limited case series. Up to now, it is the largest and most comprehensive retrospective study of CMV gastritis.

Methods: All patients who were histologically diagnosed with CMV gastritis at Linkou Chang Gung Memorial Hospital between January 2000 and April 2020 were included. Patients were divided into two groups according to immunity. Between-group differences in characteristics, manifestations, endoscopic features, prognostic factors, and outcomes were analyzed. The main endpoint was 3-month mortality.

Results: A total of 54 patients (34 immunocompromised, 20 immunocompetent) were enrolled. Common presentations included gastrointestinal bleeding (35.2%), abdominal pain (33.3%) and fever (31.5%). The endoscopic features included ulcer (88.9%) and inflammation (11.1%). The 3-month mortality rate was 20.4% and overall mortality rate was 40.7%. Acute kidney injury was the only independent risk factor for 3-month mortality (OR 53.89, 95%CI 1.56-1861.73, p = 0.027). Anti-viral therapy and host immune status did not affect 3-month mortality.

Conclusion: Both immunocompromised and immunocompetent patients with CMV gastritis have high mortality rates, without significant between-group differences. Acute kidney injury is the only independent predictive factor for 3-month mortality. Prevention of acute kidney injury may possibly improve the 3-month mortality rate.

Keywords: Cytomegalovirus (CMV); Endoscopy; Gastritis; Mortality; Prognosis.

PubMed Disclaimer